William (Bill) Dempster

CEO

3Sixty Public Affairs

As CEO of 3Sixty Public Affairs, Bill Dempster develops and implements high-impact government relations, policy and business strategies for clients in the health and life sciences sector. For over a decade, Bill has drawn on deep business, legal and government experience to help clients find mutually beneficial solutions to complex regulatory, reimbursement and policy problems. Bill has previously worked for Pfizer Canada, a Member of Parliament, the United Nations and major Canadian law firms. He is fluently bilingual and has degrees in history (King’s College, University of Western Ontario), law (Queen’s University), and a Masters of Arts in international affairs (Norman Paterson School of International Affairs, Carleton University). Bill was called to the Bar of Ontario in 2002.


All Sessions by William (Bill) Dempster

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 5, 2020

9:00 am

9:00 am

Welcome From The Chair

Gain insight into today’s sessions so you can get the most out of your experience and maximize your value.

9:10 am

9:10 am

OPENING KEYNOTE: CANADIAN HEALTHCARE LANDSCAPE

CANADA’S HEALTHCARE SYSTEM – NOT AS BAD AS WE THINK (BUT NOT QUITE AS GOOD EITHER)

Not taking a page out of the COVID-19 playbook, the federal government and Canada’s 13 premiers are back to squabbling over healthcare funding. Meanwhile Canadians feel under-served for their tax dollars, and are fed up with temporary closures of ER’s and consistent staffing issues in all facets of healthcare. Exchange ideas and perspectives with one of Canada’s most respected – and always controversial – healthcare critics on topics including:

  • where does the future of healthcare funding lie
  • what can we as an industry do to increase Canadians’ access to new drugs
  • how can we make the healthcare sector more attractive for GenZ

Share your point of view and bring back actionable ideas to your senior management

10:00 am

10:00 am

FIRESIDE CHAT: THE INCREASED OPPORTUNITY FOR PUBLIC / PRIVATE PARTNERSHIPS TO FIX THE SYSTEM

Using Cardiovascular Disease As An Important Example

The healthcare system in Canada has been under tremendous strain for years. The ongoing crisis has been amplified by the pandemic, which caused severe global disruption in the delivery of health care for non-communicable diseases, BUT early detection and diagnosis are critical to keeping people out of hospitals and reducing the need for procedures and surgeries.

Now is the time to take a closer look at how the public and private sectors can band together to drive solutions to crucial healthcare problems, alleviate pressure throughout the system, and drive positive and lasting change.

The issue of cardiovascular disease (CVD) is particularly pressing as it is the second leading cause of death in Canada after cancer and now providers are facing an unprecedented backlog in the need for follow-up care to prevent future heart attacks and strokes among people at elevated risk. Novartis is seeking to address care inequities, barriers to access, and challenges and opportunities, by investing and institutionalizing best-in-class provincial teams to drive partnerships at the local healthcare system level.

Agenda: Day 2 Oct 6, 2020

9:00 am

9:00 am

Welcome From Your Chair

Gain insight into today’s sessions so you can get the most out of your experience and maximize your value.

9:45 am

9:45 am

FIRESIDE CHAT: CADTH UPDATE

Are We Increasing The Percentage Of Submissions Approved First Time Around, or Not?

How much time in spent revising new drug submissions when you add it all up? Accurately interpreting the impact of these learnings is fundamental to your company’s bottom line. Source intelligence to:

  • Gain a comprehensive understanding of the information requirements for drug submissions to CADTH
  • Adopt best practices to better manage your product submissions under the revised process
  • Navigate through the changes seamlessly and efficiently

Position your product for a prosperous journey through the updated CADTH review process